Evidence map›Paper›PMID 40378142›Full record

ArticlePloS one2025

Pre-transplant residual diuresis and oxalic acid concentration influence kidney graft survival.

Gideon Post Hospers, Mirjam Laging, Wesley J Visser, Pedro Miranda Afonso, Jeroen Ghp Verhoeven, Ingrid Ram Mertens Zur Borg, Dennis A Hesselink, Anneke M E de Mik-van Egmond, Michiel G H Betjes, Madelon van Agteren and 8 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Gideon Post HospersDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Mirjam LagingDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Wesley J VisserDepartment of Internal Medicine, Division of Dietetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Pedro Miranda AfonsoDepartment of Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-6708-9597
Jeroen Ghp VerhoevenDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Ingrid Ram Mertens Zur BorgDepartment of Anaesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Dennis A HesselinkDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Anneke M E de Mik-van EgmondDepartment of Internal Medicine, Division of Dietetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Michiel G H BetjesDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Madelon van AgterenDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
David SeversDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Jacqueline van de WeteringDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0001-9117-2630
Robert ZietseDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Michel J VosDepartment of Clinical Chemistry Metabolic diseases, University Medical Center Groningen, The Netherlands.
Ido P KemaDepartment of Clinical Chemistry Metabolic diseases, University Medical Center Groningen, The Netherlands.
Marcia M L KhoDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Marlies E J ReindersDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.
Joke I RoodnatDepartment of Internal Medicine, Department of Nephrology and Transplantation, Transplant Institute, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0003-2548-5481

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and hypothesisOxalic acid, a toxic metabolic end product, accumulates when kidney function deteriorates. Apart from its direct tubulotoxicity, it crystallizes at concentrations above 30-40 µmol/L. High oxalic acid concentrations at transplantation might negatively influence kidney transplant function. The influence of the concentrations of oxalic acid and its precursors and residual diuresis on kidney transplant outcomes was studied.

methodsIn this prospective cohort study, patients who received a kidney transplant between September 2018 and January 2022 participated. Concentrations of oxalic acid and precursors were determined in pre-transplant blood samples. Data on residual diuresis and other recipient, donor or transplant related variables were collected. Follow-up lasted until July 1st 2023.

results496 patients were included, 154 were not on dialysis. Median residual diuresis was 1000 mL/day (IQR 200; 2000 mL/day). There were 230 living donor transplantations. Oxalic acid concentrations exceeded the upper normal concentration in 99% of patients, glyoxylic acid in all patients. There were 52 (10%) graft failures. As the influence of oxalic acid on the risk of graft failure censored for death was non-linear, it was categorized into two groups: ≤ 60 and > 60 μmol/L. In multivariable Cox analysis the graft failure censored for death risk was significantly influenced by residual diuresis, donor type (living versus deceased), donor age and oxalic acid. In 180 patients oxalic acid concentration shortly after transplantation was significantly lower than pre-transplant concentrations, suggesting excretion by the new graft. A better eGFR at day 7 was associated with lower oxalic acid concentration. Oxalic acid and residual diuresis did not influence patient survival.

conclusionResidual diuresis and oxalic acid concentration are important and independent predictors of graft survival censored for death. These results underline the importance of pre-emptive transplantation, or optimizing the pre-transplant patients' condition regarding waste product concentrations.

Indexed as

DiuresisGraft SurvivalKidney TransplantationOxalic AcidAdultFemaleGlyoxylatesHumansMaleMiddle AgedProspective StudiesGlyoxylatesglyoxylic acidOxalic Acid

Identifiers

PMID40378142
PMCPMC12083809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.